A Double-Blind, Randomized, Active Comparator Study of LT-NS001 Versus Naprosyn for Seven Days in Healthy Subjects With Endoscopic Evaluation

Trial Profile

A Double-Blind, Randomized, Active Comparator Study of LT-NS001 Versus Naprosyn for Seven Days in Healthy Subjects With Endoscopic Evaluation

Completed
Phase of Trial: Phase I

Latest Information Update: 05 Oct 2010

At a glance

  • Drugs Naproxen; Naproxen etemesil
  • Indications Musculoskeletal pain; Osteoarthritis; Pain; Rheumatoid arthritis
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Logical Therapeutics
  • Most Recent Events

    • 20 Nov 2009 Results presented at GASTRO 2009.
    • 20 Oct 2009 Results will be presented at the American College of Gastroenterology's (ACG) Annual Scientific Meeting on October 27, 2009, according to a Logical Therapeutics media release.
    • 26 May 2009 Results reported in a Medinox media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top